Source

• Risk Factors Outside Of AAP Guidelines Identify More Preemies Needing RSV Prophylaxis

  New data have emerged regarding three risk factors which may help pediatricians better identify which preterm infants are at high risk of severe respiratory syncytial virus (RSV) disease and may thus benefit from palivizumab (Synagis®) prophylaxis, investigators reported at the American Academy of Pediatrics (AAP) 2008 National Conference and Exhibition. The risk factors include cigarette smoking, crowded living conditions, and young chronologic age.
  • Discuss this news

  • 10-11-2008 06:34 PM
  • Respiratory / Asthma News From Medical News Today
  • News
  • AAP
  • RSV

•   |  
•   |  
•   |  
•   |  
•   |  
•   |  
•   |  

© 2003-2008 LuMriX.net GmbH